CHRISTINA CLARK: Open Payments
NPI 1396134961 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 11 payments from 7 companies in 2025. Trend: 2023 $443 · 2024 $738 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $401 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Eisai Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| DISTALMOTION US | 1 | $26 |
| ABBVIE INC. | 1 | $16 |
Products named: DUPIXENT, AJOVY, JEMPERLI, Lenvima, LYNPARZA, DEXTER L6 ROBOT, TRELEGY ELLIPTA, BOTOX.
Industry payments across FL — which companies pay providers there.
